• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 22

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Number of telephone and in-person briefings delivered within the month to Members of Congress and staff on current or new FDA programs, policies, and initiativesOC ADMINOffice of LegislationN/AN/A
2Number of e-mail messages sent within the month to Congressional staff informing them of new significant agency regulatory/legal actionsOC ADMINOffice of LegislationN/AN/A
3Number of current GAO Studies in progress in the monthOC ADMINOffice of Policy and PlanningN/AN/A
4Percentage of successful call backs completed during the month which are within an established acceptable timeframeOC ADMINOffice of the Counselor to the Commissioner - Office of Crisis ManagementOCTC-OCM Strategic PlanServe as the FDA's focal point for coordinating emergency and crisis response activities involving FDA regulated products
5Total number of emergency preparedness exercises which FDA participated in planning, executing, or evaluating during the monthOC ADMINOffice of the Counselor to the Commissioner - Office of Crisis ManagementOCTC-OCM Strategic PlanImprove FDA's preparedness to respond to future emergencies by coordinating intra-agency and inter-agency activities related to crisis management and emergency preparedness and response
6Cumulative percentage of employees who are identified to take ICS 300 in the current FY who have completed their trainingOC ADMINOffice of the Counselor to the Commissioner - Office of Crisis ManagementOCTC-OCM Strategic PlanAssist in the development, management, and coordination of incident management policies and programs for FDA to ensure that an agency structure exists to respond rapidly and effectively to all hazards
7Total correspondence received by OES during the month which require FDA responseOC ADMINOffice of the Executive SecretariatOES Strategic PlanRespond effectively and efficiently to external correspondence and related inquiries from industry and the general public on behalf of the Commissioner
8Number of MedWatch e-list subscribers during the monthOC ADMINOffice of External AffairsOEA Strategic PlanEnhance consumer content and engagement
9Number of new fact sheets posted on fda.gov during the monthOC ADMINOffice of External AffairsOEA Strategic PlanEnhance consumer content and engagement
10Average American Customer Satisfaction Index (ACSI) evaluation score from surveys completed on the mobile site during the monthOC ADMINOffice of External AffairsOEA Strategic PlanProvide leadership throughout the Agency on communication strategies and practices
11Number of commmunication materials cleared during the month which followed HHS clearance proceduresOC ADMINOffice of External AffairsOEA Strategic PlanProvide leadership throughout the Agency on communication strategies and practices
12Percentage increase of FDA Facebook page likes received during the monthOC ADMINOffice of External AffairsOEA Strategic PlanProvide leadership throughout the Agency on communication strategies and practices
13Social Media GuidanceOC ADMINOffice of External AffairsOEA Strategic PlanProvide leadership throughout the Agency on communication strategies and practices
14Number of visits to the FDA Patient Network Website during the monthOC ADMINOffice of External AffairsOEA Strategic PlanEnhance outreach to external stakeholders
15Average bounce rate of visitors to the newsroom on fda.gov during the monthOC ADMINOffice of External AffairsOEA Strategic PlanEnhance outreach to external stakeholders
16Establishment of FDA Newsroom on fda.govOC ADMINOffice of External AffairsOEA Strategic PlanEnhance outreach to external stakeholders
17Cumulative number of emergency preparedness exercises in which FDA participates in during the fiscal yearOC ADMINOffice of the Counselor to the Commissioner - Office of Crisis ManagementOCTC-OCM Strategic PlanImprove FDA's preparedness to respond to future emergencies by coordinating intra-agency and inter-agency activities related to crisis management and emergency preparedness and response
18Number of incidents involving FDA-regulated products that are coordinated by the Office of Emergency Operations (OEO) during the monthOC ADMINOffice of the Counselor to the Commissioner - Office of Crisis ManagementOCTC-OCM Strategic PlanServe as the FDA's focal point for coordinating emergency and crisis response activities involving FDA regulated products
19Establishment of FDA Emergency Task ForceOC ADMINOffice of the Counselor to the Commissioner - Office of Crisis ManagementOCTC-OCM Strategic PlanImprove FDA's preparedness to respond to future emergencies by coordinating intra-agency and inter-agency activities related to crisis management and emergency preparedness and response
20Number of Federal Register (FR) Docket Check requests received in the month by the Division of Dockets Management (DDM)OC ADMINOffice of the Executive SecretariatOES Strategic PlanManage review and assignment of document management process in response to requests from the Regulation Editorial Staff (RES) and process non-urgent and urgent Federal Register (FR) docket checks timely
21Cumulative number of newsletters published during the fiscal yearOC ADMINOffice of External AffairsOEA Strategic PlanImprove internal communications with FDA employees
22Internal Electronic NewsletterOC ADMINOffice of External AffairsOEA Strategic PlanImprove internal communications with FDA employees

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.